HEPATOPROTECTIVE ACTIVITY OF HYDROETHANOL EXTRACT OF CURCUMA LONGA LINN. ON PARACETAMOL AND CARBON TETRACHLORIDE-INDUCED HEPATOTOXICITY IN RATS

Authors

  • Omoniyi Kayode Yemitan Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, Lagos State University, Ikeja, Lagos, Nigeria
  • Kolade Daniel Alabi Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, Lagos State University, Ikeja, Lagos, Nigeria
  • Ayomikun Precious Bakare Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, Lagos State University, Ikeja, Lagos, Nigeria
  • Kosisochukwu Victory Arinze Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, Lagos State University, Ikeja, Lagos, Nigeria
  • Adeyemi Oluwaseun Dada Department of Pathology and Forensic, College of Medicine, Lagos State University, Ikeja, Lagos, Nigeria.
  • Abdulfatai Olakunle Ojewale Department of Anatomy, College of Medicine, Lagos State University, Ikeja, Lagos, Nigeria

DOI:

https://doi.org/10.5281/acs.v10i2.208

Keywords:

Hepatoprotective, Curcuma Longa, Paracetamol, Carbon tetrachloride, Liver function biomarkers, Histopathology

Abstract

Background: Curcuma longa Linn. is extensively used for its culinary and ethnomedicinal properties, which include claims of prevention and treatment of hepatic diseases. However, there are limited studies on the effectiveness of C. longa on drug and chemically-induced hepatotoxicity; thus, we evaluated the anti-hepatotoxic effects of doses of the hydroethanol extract of C. longa L. (HECL) using Paracetamol (PCM) and Carbon tetrachloride (CCl4) models.

Methodology: This study was conducted on forty rats randomly divided into PCM and CCl4 models of four study groups each (n=5). For the PCM model, Group I: Normal saline (NS, 10 ml/kg, p.o. ); Group II: PCM (600 mg/kg, p.o.) & 3 ml/kg NS; Group III & IV: PCM & HECL (200 & 400 mg/kg, respectively, p.o.); while the CCl4 model, Group V: Olive oil (10 ml/kg, i.p.); Group VI: CCl4 (15 ml/kg. of 20% v/v, i.p.) & olive oil; Group VII & VIII: CCl4 & HECL (100 & 300 mg/kg, respectively, p.o.). HECL was administered at 2, 6, and 10 h post-induction. Following euthanizing, blood samples were collected for liver function tests:  Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and uric acid levels were measured, while liver was excised for histopathology was assessed via hematoxylin and eosin staining. 
Results: In the PCM model, HECL (200 and 400 mg/kg) significantly reduced ALT and uric acid (p<0.05), with 400 mg/kg showing superior efficacy. AST reductions were non-significant. In the CCl4 model, CCl4 significantly increased ALT, AST, and uric acid (p<0.05). HECL (100 and 300 mg/kg) significantly lowered these biomarkers (p<0.05), with 300 mg/kg more effective. 
Conclusions: HECL elicited remarkable hepatoprotective effects, likely due to apoptotic restoration and cytosolic restoration, thereby supporting its use in ethnomedicine for prevention and treatment of liver diseases.

Author Biographies

Omoniyi Kayode Yemitan, Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, Lagos State University, Ikeja, Lagos, Nigeria

Professor, Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, Lagos State University, Ikeja, Lagos, Nigeria.

Adeyemi Oluwaseun Dada, Department of Pathology and Forensic, College of Medicine, Lagos State University, Ikeja, Lagos, Nigeria.

Department of Chemical Pathology, College of Medicine, Lagos State University, Ikeja, Lagos, Nigeria.

Abdulfatai Olakunle Ojewale, Department of Anatomy, College of Medicine, Lagos State University, Ikeja, Lagos, Nigeria

Department of Anatomy, College of Medicine, Lagos State University, Ikeja, Lagos, Nigeria

Downloads

Published

31-07-2025

How to Cite

Yemitan, O. K., Alabi, K. D., Bakare, A. P., Arinze, K. V., Dada, A. O., & Ojewale, A. O. (2025). HEPATOPROTECTIVE ACTIVITY OF HYDROETHANOL EXTRACT OF CURCUMA LONGA LINN. ON PARACETAMOL AND CARBON TETRACHLORIDE-INDUCED HEPATOTOXICITY IN RATS. Annals of Clinical Sciences, 10(2), 142–150. https://doi.org/10.5281/acs.v10i2.208